Patents by Inventor Kevin Eliceiri

Kevin Eliceiri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10045696
    Abstract: Fluorescent markers used to identify a tissue may be imaged in a bright environment by synchronizing the imaging process with rapidly switched ambient lighting so that imaging occurs in phase with a switching off of the ambient lighting. In this way, valuable fluorescent imaging may be performed in an environment that appears to be brightly illuminated, for example in the area of a surgical suite.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: August 14, 2018
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Thomas Mackie, Adam Uselmann, Andreas Velten, Surendra Prajapati, Kevin Eliceiri
  • Publication number: 20150025391
    Abstract: Fluorescent markers used to identify a tissue may be imaged in a bright environment by synchronizing the imaging process with rapidly switched ambient lighting so that imaging occurs in phase with a switching off of the ambient lighting. In this way, valuable fluorescent imaging may be performed in an environment that appears to be brightly illuminated, for example in the area of a surgical suite.
    Type: Application
    Filed: July 19, 2013
    Publication date: January 22, 2015
    Applicant: Wisconsin Alumni Research Foundation
    Inventors: Thomas Mackie, Adam Uselmann, Andreas Velten, Surendra Prajapati, Kevin Eliceiri
  • Publication number: 20080015448
    Abstract: The present invention provides methods and systems for evaluating biological materials for the diagnosis of disease, such as gland abnormalities, and the cancerous and precancerous conditions. Nonlinear optical microscopy techniques, such as MP microscopy and harmonic generation microscopy, are used to generate high resolution, three dimensional images of a test tissue, such as a biopsy tissue sample and tissue in whole organisms, that are analyzed, optionally in combination, to detect, identify and characterize tumor-associated collagen signatures. The presence, abundance and extent of histological features and structural motifs comprising tumor-associated collagen signatures may be directly and accurately correlated with the onset and progression of cancer, such as breast cancer. The present methods are capable of providing an accurate and selective diagnosis of cancer, and provide diagnostic information complementary to conventional diagnostic methods.
    Type: Application
    Filed: June 21, 2007
    Publication date: January 17, 2008
    Inventors: Patricia Keely, Paolo Provenzano, John White, Kevin Eliceiri